BRO vs MGX · P/E 30, rev $3.58B vs rev $25.2M
Brown & Brown Inc (BRO) versus Metagenomi, Inc. Common Stock (MGX) — a side-by-side from cached financials, not a winner call.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Metagenomi, Inc. Common Stock (MGX) is a biotechnology company listed on NASDAQ.
Latest reported BRO revenue for 2026-06-30 was $3.58B. Net income was $714.0M. Revenue was up 88.2% from 2026-03-31 to 2026-06-30. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Latest reported MGX revenue for 2025-12-31 was $25.2M. Net income was -$87.9M. Revenue was down 51.8% from 2024-12-31 to 2025-12-31. MGX currently screens at market cap $44.4M.
BRO currently screens at market cap $35.56B and trailing P/E 30.0. MGX currently screens at market cap $44.4M.
Not investment advice. Open the BRO and MGX stock pages for the full models.
Not investment advice.